Related Experiment Video
Updated: Nov 1, 2025

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans
Abstract:
Candida albicans is a prevalent opportunistic human fungal pathogen for which treatment is limited to only four main classes of antifungal drugs, with the azole and echinocandin classes being used most frequently. Drug tolerance, the ability of some cells to grow slowly in supra-MIC drug concentrations, decreases the number of available treatment options. Here, we investigated factors affecting tolerance and resistance to ketoconazole in C. albicans. We found both temperature and the composition of growth medium significantly affected tolerance with little effect on resistance. In deletion analysis of known efflux pump genes, CDR1 was partially required for azole tolerance, while CDR2 and MDR1 were dispensable. Tolerance also required Hsp90 and calcineurin components; CRZ1, which encodes a transcription factor downstream of calcineurin, was required only partially. Deletion of VMA11, which encodes a vacuolar ATPase subunit, and concanamycin A, a V-ATPase inhibitor, abolished tolerance, indicating the importance of vacuolar energy transactions in tolerance. Thus, tolerance to ketoconazole is regulated by multiple factors, including physiological and genetic mechanisms. IMPORTANCE Due to the ever-expanding range of invasive medical procedures and treatments, invasive fungal infections now pose a serious global threat to many people living in an immunocompromised status. Like humans, fungi are eukaryotic, which significantly limits the number of unique antifungal targets; the current arsenal of antifungal agents is limited to just three frontline drug classes. Additional treatment complexities result from the development of drug tolerance and resistance, which further narrows therapeutic options; however, the difference between tolerance and resistance remains largely unknown. This study demonstrates that tolerance and resistance are regulated by multiple genetic and physiological factors. It is prudent to note that some factors affect tolerance only, while other factors affect both tolerance and resistance. The complex underlying mechanisms of these drug responses are highlighted by the fact that there are both shared and distinct mechanisms that regulate tolerance and resistance.
Insights
Drug tolerance in Candida albicans is influenced by temperature, growth medium, and specific genes like CDR1. Vacuolar function is crucial for ketoconazole tolerance, highlighting complex regulatory mechanisms against fungal infections.
Area of Science:
- Mycology
- Antimicrobial Resistance
Background:
- Candida albicans is a major opportunistic fungal pathogen with limited treatment options.
- Antifungal drug tolerance and resistance reduce therapeutic efficacy, posing a global health threat, especially to immunocompromised individuals.
Purpose of the Study:
- Investigate factors influencing ketoconazole tolerance and resistance in Candida albicans.
- Differentiate mechanisms underlying drug tolerance versus resistance.
Main Methods:
- Deletion analysis of efflux pump genes (CDR1, CDR2, MDR1).
- Assessed the role of Hsp90, calcineurin pathway components (CRZ1), and vacuolar ATPase (VMA11).
- Utilized concanamycin A to inhibit vacuolar ATPase activity.
Main Results:
- Temperature and growth medium composition significantly impacted ketoconazole tolerance but not resistance.
- CDR1 partially contributed to azole tolerance; CDR2 and MDR1 were dispensable.
- Hsp90, calcineurin, and CRZ1 were involved in tolerance, with CRZ1 showing partial requirement.
- Deletion of VMA11 or V-ATPase inhibition abolished tolerance, emphasizing vacuolar energy transaction importance.
Conclusions:
- Ketoconazole tolerance in C. albicans is regulated by a combination of physiological and genetic factors.
- Distinct and shared mechanisms govern drug tolerance and resistance, underscoring the complexity of antifungal drug response.
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Factors Affecting Drug Response: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Desensitization and Tachyphylaxis

